Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
More than 40% of Americans are paying for subscriptions they have forgotten about, according to data from C+R Research. These forgotten plans cost an average of $17 a month or more than $200 per month ...
New York Deputy Solicitor General Ester Murdukhayeva argued that the state's Equal Rights Amendment had not expressly or implicitly repealed a separate provision of the constitution requiring state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results